Home
Arthur Taveras, Chief Scientific Officer: X4 Pharmaceuticals XFOR Sell · Filed 23/02/15
Trade details
- Type
- Insider sale
- Amount
- $863.04
- Shares · price
- 928 sh · $0.93 a share
- Held after
- 103,179 sh
- Trade date
- 23/02/13
- Filed
- 23/02/15
- Days to filing
- 2 days
Sold 0.9% of holdings
- Share of holding sold
- 0.9%
X4 Pharmaceuticals trades, last 26 weeks
What else happened in X4 Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/01/14~23/03/15Arthur Taveras's recent trades
- Arthur Taveras
Planned sale10b5-1 planX4 Pharmaceuticals
Planned sale10b5-1 planX4 Pharmaceuticals
XFOR
$12.9K
24,828 sh
$12.9K
Filed 25/01/24
Traded 25/01/24
- Arthur Taveras
SellX4 Pharmaceuticals
SellX4 Pharmaceuticals
XFOR
$43.1K
76,920 sh
$43.1K
Filed 24/10/08
Traded 24/10/07
- Arthur Taveras
SellX4 Pharmaceuticals
SellX4 Pharmaceuticals
XFOR
$12.5K
14,235 sh
$12.5K
Filed 24/03/11
Traded 24/03/11
- Arthur Taveras
SellX4 Pharmaceuticals
SellX4 Pharmaceuticals
XFOR
$795
787 sh
$795
Filed 24/02/12
Traded 24/02/12
- Arthur Taveras
Sell10b5-1 planX4 Pharmaceuticals
Sell10b5-1 planX4 Pharmaceuticals
XFOR
$49.4K
67,695 sh
$49.4K
Filed 23/11/03
Traded 23/11/01